Significant Ownership of Woodline Partners LP

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Woodline Partners LP focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Erin Mullen - By: Erin Mullen, General Counsel & Chief Compliance Officer
Manager location
San Francisco, CA

Follow Filing Activity

Follow Woodline Partners LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here

Significant Ownership of Woodline Partners LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
QNRX Quoin Pharmaceuticals, Ltd. Ordinary Shares, no par value per share 9.5% $38,298,838 2,785,370 Woodline Partners LP 31 Dec 2025
AIRO AIRO Group Holdings, Inc. Common Stock, par value $0.000001 per share 8.5% $52,858,886 +$15,368,755 2,753,067 +41% Woodline Partners LP 30 Sep 2025
ZVRA Zevra Therapeutics, Inc. Common Stock, par value $0.0001 per share 8.1% $63,076,462 +$17,260,897 4,785,771 +38% Woodline Partners LP 30 Jun 2026
CALC CalciMedica, Inc. Common Stock, par value $0.0001 per share 8.1% $2,041,578 2,489,729 Woodline Partners LP 30 Jun 2026
OM Outset Medical, Inc. Common Stock, par value $0.001 per share 7.5% $15,392,352 1,325,784 Woodline Partners LP 31 Mar 2025
OKYO OKYO Pharma LTD Ordinary Shares, no par value 7% $5,587,851 3,652,190 Woodline Partners LP 31 Mar 2026
SABS SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 6.8% $21,603,206 -$6,615,283 5,455,355 -23% Woodline Partners LP 30 Jun 2026
EQ Equillium, Inc. Common Stock, par value $0.0001 per share 5.9% $5,016,841 3,508,771 Woodline Partners LP 30 Sep 2025
XOMA XOMA Royalty Corp Common Stock, par value $0.0075 5.4% $24,736,039 640,001 Woodline Partners LP 31 Mar 2026
BHVN Biohaven Ltd. Common Shares, no par value per share 5.1% $120,726,013 7,660,280 Woodline Partners LP 30 Jun 2026
CRVO CervoMed Inc. Common Stock, par value $0.001 per share 5.1% $2,459,684 688,987 Woodline Partners LP 30 Jun 2026
TNYA Tenaya Therapeutics, Inc. Common Stock, par value $0.0001 per share 5% $6,120,000 +$2,097,006 9,000,000 +52% Woodline Partners LP 30 Jun 2025
SGMT Sagimet Biosciences Inc. Series A Common Stock, par value $0.0001 per share 4.8% $10,299,309 -$7,211,088 1,501,357 -41% Woodline Partners LP 30 Sep 2025
BJRI BJ's Restaurants, Inc. Common Stock, no par value per share 4.6% $37,600,627 -$2,816,988 983,280 -7% Woodline Partners LP 31 Mar 2026
GRDN Guardian Pharmacy Services, Inc. Class A Common Stock, par value $0.001 per share 4.5% $10,004,392 415,120 Woodline Partners LP 31 Dec 2024
ALGS Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share 4.4% $2,068,088 -$430,332 239,362 -17% Woodline Partners LP 31 Mar 2026
VSH Vishay Intertechnology, Inc. Common Stock, par value $0.10 per share 4% $93,996,457 -$97,834,820 4,952,395 -51% Woodline Partners LP 31 Mar 2026
TARA Protara Therapeutics, Inc. Common Stock, par value $0.001 per share 3.9% $5,751,035 1,331,258 Woodline Partners LP 31 Dec 2024
PLRX PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 3.3% $2,471,953 -$3,023,924 2,026,191 -55% Woodline Partners LP 31 Dec 2025
ACET Adicet Bio, Inc. Common Stock, par value $0.0001 per share 3.3% $2,132,374 -$2,123,876 313,124 -50% Woodline Partners LP 31 Mar 2026
TNGX Tango Therapeutics, Inc. Common Stock, par value $0.001 per share 2.5% $122,577,373 -$122,543,025 4,000,567 -50% Woodline Partners LP 30 Jun 2026
TVTX Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share 2.4% $38,750,646 2,114,056 Woodline Partners LP 31 Dec 2024
OM Outset Medical, Inc. Common Stock, par value $0.001 per share 1.6% $5,372,097 292,437 Woodline Partners LP 31 Mar 2026
BRCB Black Rock Coffee Bar, Inc. Class A Common Stock, par value $0.00001 per share 0% $0 -$7,923,748 0 -100% Woodline Partners LP 30 Jun 2026

Schedules 13D/G Reported by Woodline Partners LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .